Analysis of publically available single-cell data from human PDAC tumors (GSE154778) (49) suggested that CD73 was mainly expressed in malignant cells, supporting the idea that CD73 inhibition will mainly affect cancer cells (fig. The gene discussed is NT5E; the disease is cancer.